Dykema Advises Wellgistics Health, Inc. on Nasdaq IPO

Congratulations to Dykema’s client, Wellgistics Health, Inc. (Nasdaq: WGRX), on the successful completion of its initial public offering (IPO). Wellgistics’ common stock began trading on the Nasdaq Capital Market under the ticker symbol “WGRX” on February 21, 2025.

Headquartered in Tampa, Florida, Wellgistics is a healthcare technology and pharmaceutical services holding company with a portfolio that includes a technology platform, pharmacy, and wholesale operations. The company provides innovative prescription hub and clinical services designed to enhance access, care coordination, dispensing, delivery, and clinical management of pharmaceutical products.

The IPO, which included the sale of 888,889 shares of common stock at a public offering price of $4.50 per share, provides Wellgistics with increased capitalization and financial flexibility. The proceeds from the offering will support the company’s strategic growth initiatives, working capital, marketing efforts, and capital expenditures.

The Dykema team assisting with this transaction was led by Kate Bechen and included Robin Lehninger, Louis Kern, and Jill Knutson.